Science Explorer Interactive view Map
Company · Tampa · United States

Modulation Therapeutics (United States)

modulationtherapeutics.comROR OpenAlex
Research works
64
▲ 7% vs 2013–17
Citations
928
14.5 per fractional work
Top-10% rate
3.1%
record average 16.5%
Open access
28%
world 28%

Not ranked overall: Modulation Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.98× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.05× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 3.86× its world share, 0 worksImmunology and Micro…Neuroscience: 0.81× its world share, 0 worksNeuroscienceEngineering: 0.10× its world share, 0 worksEngineeringMedicine: 3.19× its world share, 4 worksMedicinePsychology: 0.13× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.0×. Every wedge is a field page.

Which keywords describe research at Modulation Therapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Gene Therapy, Immunotherapy, Glycosylation, Cancer Therapy, Monoclonal Antibodies, Therapeutic Antibodies, PET Imaging and Targeted Therapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Gene Therapy7▲ 41×4 topics
  2. Immunotherapy6▲ 13×9 topics
  3. Glycosylation5▲ 38×3 topics
  4. Cancer Therapy4▲ 10×8 topics
  5. Cancer4▲ 4.6×13 topics
  6. Inflammation4▲ 2.7×14 topics
  7. Monoclonal Antibodies4▲ 41×2 topics
  8. Therapeutic Antibodies4▲ 46×2 topics
  9. PET Imaging3▲ 24×2 topics
  10. Targeted Therapy3▲ 24×3 topics
  11. AAV3▲ 76×1 topic
  12. Viral Vectors3▲ 76×1 topic
  13. Antibody Engineering3▲ 47×1 topic
  14. Fc Receptors3▲ 47×1 topic
  15. Tumor Regression3▲ 54×2 topics
  16. Radioimmunotherapy3▲ 114×1 topic
  17. Radiopharmaceuticals3▲ 114×1 topic
  18. Tumor Targeting3▲ 33×3 topics
  19. Cell Death3▲ 20×3 topics
  20. Genetic Mutations2▲ 7.4×6 topics
  21. Monoclonal Antibody2▲ 54×2 topics
  22. Arginine Deprivation2▲ 81×1 topic
  23. BRCA Mutation2▲ 215×1 topic
  24. Bacterial Therapy2▲ 81×1 topic
  25. PARP Inhibitors2▲ 215×1 topic
  26. Biomarkers2▲ 5.6×5 topics
  27. Transcriptional Regulation2▲ 14×4 topics
  28. Chemotherapy2▲ 4.7×7 topics
  29. Apoptosis2▲ 8.0×6 topics
  30. Clinical Trials2▲ 5.0×5 topics
  31. Imaging2▲ 9.0×3 topics
  32. Mammalian Cells2▲ 77×1 topic
  33. Recombinant Protein2▲ 77×1 topic
  34. Cancer Immunotherapy2▲ 19×2 topics
  35. Innate Immunity2▲ 7.5×4 topics
  36. Pharmacology2▲ 8.1×5 topics
  37. Drug Discovery2▲ 6.5×3 topics
  38. Neurodegeneration2▲ 7.7×5 topics
  39. Nuclear Receptors2▲ 13×2 topics
  40. PET/CT2▲ 31×1 topic

Which research topics does Modulation Therapeutics (United States) publish most on?

By volume in 2022–2025: PARP inhibition in cancer therapy, Phosphodiesterase function and regulation, Cholinesterase and Neurodegenerative Diseases and Lung Cancer Research Studies.

PARP inhibition in cance…2PARP inhibition in cancer therapy: 2 fractional worksPhosphodiesterase function and regulation: 0 fractional worksCholinesterase and Neuro…0Cholinesterase and Neurodegenerative Diseases: 0 fractional worksLung Cancer Research Stu…0Lung Cancer Research Studies: 0 fractional worksPhytochemistry and biolo…0Phytochemistry and biological activities of Ficus species: 0 fractional worksCancer therapeutics and mechanisms: 0 fractional worksRNA and protein synthesis mechanisms: 0 fractional worksCellular transport and secretion: 0 fractional worksAdipose Tissue and Metabolism: 0 fractional worksRNA modifications and cancer: 0 fractional works
OncologyMolecular BiologyPharmacologyPlant Science2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 PARP inhibition in cancer therapy Oncology 2 works
  2. 2 Phosphodiesterase function and regulation Molecular Biology 0 works
  3. 3 Cholinesterase and Neurodegenerative Diseases Pharmacology 0 works
  4. 4 Lung Cancer Research Studies Oncology 0 works
  5. 5 Phytochemistry and biological activities of Ficus species Plant Science 0 works
  6. 6 Cancer therapeutics and mechanisms Molecular Biology 0 works
  7. 7 RNA and protein synthesis mechanisms Molecular Biology 0 works
  8. 8 Cellular transport and secretion Cell Biology 0 works
  9. 9 Adipose Tissue and Metabolism Physiology 0 works
  10. 10 RNA modifications and cancer Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available28.3%not open71.7%

World: 28% of research is openly available.

with international co-authors28.8%domestic only71.2%

World: 19% is written across borders.

How has Modulation Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 7% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tampa

All research institutions in Tampa

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.